Morgan Stanley 13D and 13G filings for Treace Medical Concepts, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:38 pm Sale | 2024-12-31 | 13G | Treace Medical Concepts, Inc. TMCI | MORGAN STANLEY MS | 2,091,809 3.400% | -1,122,182 (-34.92%) | Filing |
| 2024-11-08 3:52 pm Purchase | 2024-09-30 | 13G | Treace Medical Concepts, Inc. TMCI | MORGAN STANLEY MS | 3,213,991 5.200% | 3,213,991 (New Position) | Filing |
| 2024-11-08 3:44 pm Purchase | 2024-09-30 | 13G | Treace Medical Concepts, Inc. TMCI | MORGAN STANLEY MS | 3,213,991 5.200% | 3,213,991 (New Position) | Filing |